Toremifene citrate

枸橼酸托瑞米芬

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameToremifene citrate
Drug Alias Name托咪酚枸橼酸盐枸橼酸托咪酚托瑞米芬枸橼酸盐FarestonEstrimex +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors modulators
TargetsEstrogen receptors
Therapy Area/IndicationsFractures, BoneOsteoporosisPrecancerous Conditions +[7] 
Global Approved IndicationsBreast Neoplasms
Approved Indications in ChinaBreast Neoplasms
Original Approved Country/TerritoryFinland
Original Approved Date1988/01/01
Country/TerritoryCanadaUnited StatesMexico +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOrion Corp
China Registration ClassN/A

Develop Information

Active CompaniesOrion CorpFuan Pharmaceutical Group Ningbo Team Pharmaceutical Co Ltd
Inactive CompaniesKyowa KirinGtx IncNational Cancer Institute +[4] 
Active IndicationsBreast Neoplasms
Inactive IndicationsFractures, BoneOsteoporosisPrecancerous Conditions +[6] 

Other Information

ATC CodeL02BA02
Related LinksWikipediaDrugBankKEGG